URGENT PANDEMIC INFORMATION

In light of the pandemic situation all of our 2021 events are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List


Proteome- Targeted Drug Discovery Summit 2021


Date
Jun 28, 2021 - 08:00 AM - Jun 29, 08:00 AM
Organizer
Hanson Wade
Venue
Wyndham Boston Beacon Hill
Location
5 Blossom Street,

Boston,
MA,
USA,
ZIP: 02114
Phone: 16174554188

Ticket Price: USD 499.0 to USD 3799.0


Improve the Rational Design and Translation of Next Generation Small Molecules to Successfully Drug Highly Desirable, Yet Difficult to Reach "Undruggable" Targets

As the renaissance in small molecule drug discovery continues and with over 80% of the proteome waiting to be drugged, the inaugural Proteome- Targeted Drug Discovery Summit 2021 has been founded with the sole purpose to help biopharma drug developers and academic research institutes finally overcome the "undruggable" nature of hard to reach, yet immensely desirable proteome targets.

KEY Features of the Proteome- Targeted Drug Discovery Summit:

World-class speaker faculty from the likes of Amgen, AstraZeneca, Pfizer and Novartis
Curated learning journey from early discovery to clinical development
Critical strategic discussions and case studies focused on the current trends, challenges and opportunities of proteome drug discovery
Intimate networking with key decision-makers from large pharma, biotech and academia through high-quality discussions

"This meeting is set out to explore a particularly exciting area of drug discovery and given the excellent line-up I hope to gather interesting insights, feedback and new ideas that can ultimately move us closer to systematically drugging the undruggable"

Markus Muellner, CTO, PhoreMost Ltd

"I look forward to hear and discuss about novel approaches to well validated and highly desirable yet difficult or undruggable drug targets"

Xin Huang, Head of Structural Biology, Amgen

URLs:
Tickets: https://go.evvnt.com/366920-0?pid=1052
Brochure: https://go.evvnt.com/366920-3?pid=1052

Prices:
Conference Only (Industry Pricing): USD 2899.0,
Conference + 1 Workshop (Industry Pricing): USD 3299.0,
Conference + 2 Workshops (Industry Pricing): USD 3799.0,
Workshops each (Industry Pricing): USD 599.0,
Conference Only (Academic Pricing): USD 1999.0,
Conference + 1 Workshop (Academic Pricing): USD 2498.0,
Conference + 2 Workshops (Academic Pricing): USD 2997.0,
Workshops each (Academic Pricing): USD 499.0


Speaker Details


Alexander V. Statsyuk, University of Houston, Angela N. Koehler, Koch Institute for Integrative Cancer Research at MIT, Daniel Finley, Harvard Medical School, Daniel Nomura, University of California, Berkeley, David Millan, Foghorn Therapeutics, Eric S. Fischer, Dana-Farber Cancer Institute, Gerald Shipps, Pfizer, Gregory P. Way, Broad Institute, Haian Fu, Emory University School of Medicine, Jeffrey Iwig, Carmot Therapeutics, John S. Lazo, University of Virginia, Markus Muellner, PhoreMost Ltd, Matthew LaMarche, Novartis, Milka Kostic, Dana-Farber Cancer Institute, Nello Mainolfi, Kymera Therapeutics, Nicolas Thomä, Friedrich Miescher Institute for Biomedical Research, Roman C. Hillig, Bayer AG, Stephan Schürer, University of Miami, Stephanos Ioannidis, Forma Therapeutics, Xin Huang, Amgen, Paola Castaldi, AstraZeneca

Event Categories
Keywords: conference




Comments








Events Calendar

SunMonTueWedThuFriSat
30 31 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 1 2 3

Newsletters

VIP Life Time Subscription to our Newsletters!
$399.99
$299.99